Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ongoing protocols for non-AIDS primary central nervous system lymphoma.

K Hoang-Xuan1, J Y Delattre

  • 1Clinique Neurologique et INSERM U495, Division Mazarin, Hôpital de la Salpêtrière, Paris, France.

Journal of Neuro-Oncology
|November 24, 1999
PubMed
Summary

Optimal treatment for primary CNS lymphoma (PCNSL) is still unclear. Current studies explore methotrexate chemotherapy with radiation, while others test chemotherapy alone to reduce cognitive side effects, especially in elderly patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRI features of pleomorphic xanthoastrocytoma defined by DNA methylation profile.

Revue neurologique·2025
Same author

Granulomatous angiitis of the central nervous system (GANS) associated with Hodgkin lymphoma.

Revue neurologique·2025
Same author

Primary central nervous system lymphoma of the spinal cord: A LOC network cohort study.

Revue neurologique·2024
Same author

Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Prognosis of glioblastoma patients improves significantly over time interrogating historical controls.

European journal of cancer (Oxford, England : 1990)·2024
Same author

Epileptic seizures in patients with primary central nervous system lymphoma: A systematic review.

Revue neurologique·2023

Area of Science:

  • Neuro-oncology
  • Clinical trial research
  • Hematology

Background:

  • Primary central nervous system lymphoma (PCNSL) treatment strategies are not standardized.
  • High-dose methotrexate-based chemotherapy combined with brain irradiation is a common approach.
  • Neurotoxicity from combined treatment is a concern, particularly in elderly patients.

Purpose of the Study:

  • To review ongoing multi-institutional clinical protocols for PCNSL.
  • To summarize current treatment evaluation methods for PCNSL.
  • To highlight specific protocols designed for elderly PCNSL patients.

Main Methods:

  • Review of current multi-institutional phase II studies for PCNSL.
  • Analysis of protocols evaluating combination chemotherapy and radiation.

Related Experiment Videos

  • Examination of trials focusing on chemotherapy-alone approaches.

    • Main Results:

    • Most current protocols assess combination high-dose methotrexate chemotherapy and brain irradiation.
    • Some trials investigate chemotherapy alone to mitigate long-term cognitive deficits.
    • Specific protocols are being developed for elderly populations due to neurotoxicity risks.

    Conclusions:

    • The optimal treatment for PCNSL requires further definition.
    • Ongoing research explores various therapeutic combinations and sequences.
    • Age-specific treatment modifications are crucial for managing neurotoxicity in PCNSL.